Sun.Mar 31, 2024

article thumbnail

Biosimilar Competition Does Not Reduce Patient Out-of-Pocket Costs for Biologic Drugs

Drug Patent Watch

A recent study published in JAMA Health Forum sheds light on the impact of biosimilar competition on patient out-of-pocket (OOP) costs for biologic drugs in the United States.

article thumbnail

Congressional Hearing on LDTs: Split on FDA Regulation but Support for VALID

FDA Law Blog: Biosimilars

By Ana Loloei & Jeffrey N. Gibbs — On March 21, 2024, the House Energy and Commerce held a subcommittee hearing titled “Evaluating Approaches to Diagnostic Test Regulation and the Impact of the FDA’s Proposed Rule.” House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Subcommittee Chair Brett Guthrie (R-KY), in announcing the hearing, made their views clear: “FDA has proposed a rule that relies upon dubious and misguided legal, economic, and public health arguments and

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New patent expiration for The Medicines drug IONSYS

Drug Patent Watch

Annual Drug Patent Expirations for IONSYS Ionsys is a drug marketed by The Medicines Co and is included in one NDA. There are eight patents protecting this drug.

Drugs 98
article thumbnail

Researchers produce grafts that replicate the human ear

Science Daily: Pharmacology News

Using state-of-the-art tissue engineering techniques and a 3D printer, researchers have assembled a replica of an adult human ear that looks and feels natural. The study offers the promise of grafts with well-defined anatomy and the correct biomechanical properties for those who are born with a congenital malformation or who lose an ear later in life.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Megan Jensen represents Perficient at SUGCON Europe 2024

Perficient: Drug Development

SUGCON 2024 is coming! Some of you involved into Sitecore community have come across of Megan Jensen ‘s catchy personal branding – “ MJ Knows Sitecore ” ( and she indeed knows it! ). This year Megan will prove that to the entire community by presenting her topic “ Optimizing for Headless: SEO Tips, Tricks, and Special Considerations for the New Composable World ” at the event’s Marketing track.

article thumbnail

New tentative approval for MYLAN drug efavirenz, emtricitabine and tenofovir alafenamide

Drug Patent Watch

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.

More Trending

article thumbnail

Which pharmaceutical companies have the most SPCs in Ireland?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Ireland.

article thumbnail

Clear Signage in Public Spaces for Universal Accessibility Series: Enhancing Safety – 2

Perficient: Drug Development

Welcome back to our series on Clear Signage in Public Spaces for Universal Accessibility! In this installment, we’ll delve into how clear signage contributes to enhancing safety in public spaces for individuals of all abilities. Let’s explore why safety is paramount and how clear signage plays a crucial role in promoting it. The Importance of Safety in Public Spaces Safety is a fundamental concern in public spaces, ensuring the well-being and security of all individuals who navigate

Vaccine 52
article thumbnail

Clear Signage in Public Spaces for Universal Accessibility Series: Promoting Independence – 3

Perficient: Drug Development

Welcome back to our series on Clear Signage in Public Spaces for Universal Accessibility! In this segment, we’ll explore how clear signage promotes independence for individuals of all abilities in public spaces. Let’s delve into why independence is crucial and how clear signage plays a vital role in fostering it. The Importance of Independence in Public Spaces Independence is a fundamental aspect of individual autonomy and empowerment, allowing individuals to navigate public spaces f

52